Vivos Therapeutics, Inc. financial data

Symbol
VVOS on Nasdaq
Location
7921 Southpark Plaza,, Suite 210, Littleton, CO
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 19, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 100 % +27.5%
Debt-to-equity 302 % +16.9%
Return On Equity -351 % -4.85%
Return On Assets -87.4 % +6.56%
Operating Margin -94.3 % -9.95%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 7.5M shares +55.2%
Common Stock, Shares, Outstanding 8.27M shares +73.5%
Entity Public Float 7.4M USD -51.6%
Common Stock, Value, Issued 1K USD
Weighted Average Number of Shares Outstanding, Basic 11M shares +65.7%
Weighted Average Number of Shares Outstanding, Diluted 11M shares +65.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 17.3M USD +18.8%
Research and Development Expense 100K USD -50%
Selling and Marketing Expense 1.43M USD -25.7%
General and Administrative Expense 23.5M USD +23.9%
Operating Income (Loss) -16.3M USD -30.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -17.1M USD -36.1%
Net Income (Loss) Attributable to Parent -17.1M USD -36.1%
Earnings Per Share, Basic -1 USD/shares +81%
Earnings Per Share, Diluted -1 USD/shares +81%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.09M USD -51.1%
Accounts Receivable, after Allowance for Credit Loss, Current 2.13M USD +370%
Assets, Current 5.79M USD -21.8%
Property, Plant and Equipment, Net 5.64M USD +70.1%
Operating Lease, Right-of-Use Asset 3.38M USD +200%
Intangible Assets, Net (Excluding Goodwill) 2.17M USD +467%
Goodwill 8.45M USD +197%
Assets 25.6M USD +67.1%
Accounts Payable, Current 2.1M USD +95.6%
Accrued Liabilities, Current 2.68M USD +30.6%
Contract with Customer, Liability, Current 537K USD -59.1%
Liabilities, Current 7.44M USD +45.1%
Long-term Debt and Lease Obligation 1.2M USD 0%
Contract with Customer, Liability, Noncurrent 1K USD -99.4%
Operating Lease, Liability, Noncurrent 2.87M USD +147%
Other Liabilities, Noncurrent 1.4M USD
Liabilities 23.1M USD +201%
Retained Earnings (Accumulated Deficit) -118M USD -16.9%
Stockholders' Equity Attributable to Parent 2.53M USD -67%
Liabilities and Equity 25.6M USD +67.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.8M USD -50.9%
Net Cash Provided by (Used in) Financing Activities 3.64M USD -50.6%
Net Cash Provided by (Used in) Investing Activities -122K USD +19.2%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 8.27M shares +73.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.92M USD -505%
Deferred Tax Assets, Valuation Allowance 21.5M USD +11.3%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 21.8M USD +10.7%
Operating Lease, Liability 1.51M USD -24.2%
Depreciation 1.2M USD +140%
Payments to Acquire Property, Plant, and Equipment 122K USD -19.2%
Lessee, Operating Lease, Liability, to be Paid 1.73M USD -26.8%
Property, Plant and Equipment, Gross 8.67M USD +43.5%
Operating Lease, Liability, Current 734K USD +51.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 507K USD -14.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 585K USD -5.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 213K USD -40.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 493K USD -2.76%
Deferred Tax Assets, Operating Loss Carryforwards 19.9M USD +14.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 133K USD -73%
Operating Lease, Payments 153K USD
Additional Paid in Capital 121M USD +11%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 100K USD 0%
Depreciation, Depletion and Amortization 177K USD +21.2%
Deferred Tax Assets, Net of Valuation Allowance 255K USD -25%
Share-based Payment Arrangement, Expense 500K USD -50%
Interest Expense 500K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%